Mike Hosking, the host of Newstalk ZB’s Morning Show, spoke with Richard Little about the launch of the AUT/WDHB trial that is now underway with 116 chronic pain patients from Auckland.
They discussed the potential for Axon to be rolled out to hospitals and medical clinics worldwide by mid 2022, results from the earlier UK PoC trial, along with an outline of the process each patient will go through during the duration of the trial.
Comments